(Q34310848)

1 August 2017

1 reference

title

Cognitive impairment in substance abuse (English)

1 reference

1 August 2017

main subject

cognitive dysfunction

1 reference

Peter W Vik

1

1 reference

1 August 2017

Tony Cellucci

series ordinal

2

1 reference

1 August 2017

Amy Jarchow

series ordinal

3

1 reference

1 August 2017

Jill Hedt

series ordinal

4

1 reference

1 August 2017

publication date

1 March 2004

1 reference

Psychiatric Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

27

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

97-109, ix

1 reference

Experience-dependent neuropsychological recovery and the treatment of chronic alcoholism

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

The residual neuropsychological effects of cannabis: the current status of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

The residual cognitive effects of heavy marijuana use in college students.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Does heavy marijuana use impair human cognition and brain function?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Attention and memory in illicit amphetamine users: comparison with non-drug-using controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Attention and memory in illicit amphetamine users

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Cognitive impairment in individuals currently using methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Decision making by methamphetamine-dependent subjects is associated with error-rate-independent decrease in prefrontal and parietal activation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Do hallucinogens cause residual neuropsychological toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Flashbacks and memory phenomena. A comment on "Flashback phenomena - clinical and diagnostic dilemmas"

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

The psychedelics: love or hostility potion?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Repeated LSD ingestion and performance on neuropsychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Organicity Measures Following Repeated LSD Ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Psychedelic drug flashbacks: Attentional deficits?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Neuropsychological and EEG disturbances in polydrug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Longitudinal influence of prenatal cocaine exposure on child language functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

A neuropsychologic profile of adolescent alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Cognitive capacity in female adolescent substance abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Neuropsychological correlates of adolescent substance abuse: four-year outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Neurocognitive functioning of adolescents: effects of protracted alcohol use.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Substance use and withdrawal: neuropsychological functioning over 8 years in youth.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Cognitive rehabilitation of chronic alcohol abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Implications of cognitive impairment for the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Neurocognitive impairment associated with alcohol use disorders: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

The neuropsychological test performance of drug-abusing patients: an examination of latent cognitive abilities and associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Treatment settings for persons with alcoholism: evidence for matching clients to inpatient versus outpatient care

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

Matching alcoholics to coping skills or interactional therapies: posttreatment results

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900110-2

7 January 2021

10.1016/S0193-953X(03)00110-2

Identifiers

DOI

1 reference

1 August 2017

1 reference